Descrizione

Final supplementary structural data for the dopamine transporter study, completing the comprehensive characterization of hDAT architecture and pharmacology.

Figure 32

Diagram

Source Paper

Structure of the human dopamine transporter and mechanisms of inhibition.

Nature (2024)

PMID: 39112705

DOI: 10.1038/s41586-024-07739-9

Cite This Figure

![Figure 32: Final supplementary structural data for the dopamine transporter study, completing the comprehensive characterization of hDAT architecture and pharmacology.]()

> Source: Dushyant Kumar Srivastava et al. "Structure of the human dopamine transporter and mechanisms of inhibition.." *Nature*, 2024. PMID: [39112705](https://pubmed.ncbi.nlm.nih.gov/39112705/)

<figure>
  <img src="" alt="Final supplementary structural data for the dopamine transporter study, completing the comprehensive characterization of hDAT architecture and pharmacology." />
  <figcaption>Figure 32. Final supplementary structural data for the dopamine transporter study, completing the comprehensive characterization of hDAT architecture and pharmacology.<br>  Source: Dushyant Kumar Srivastava et al. "Structure of the human dopamine transporter and mechanisms of inhibition.." <em>Nature</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39112705/">39112705</a></figcaption>
</figure>

Evidenze correlate

Zinc per Neurotransmitter Imbalance

Grado C · 8 studi